BDNF and myeloid sarcoma: It is thus tempting to speculate that reduction of BDNF levels after the first MS attack may be an indicator of early activation of proinflammatory glial cells in widespread brain regions, thereby contributing to high disease activity through the release of mediators that are toxic for neurons and oligodendrocytes.